These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 2170059)

  • 1. 1990 Medicare/CLIA final rules for proficiency testing: minimum intralaboratory performance characteristics (CV and bias) needed to pass.
    Ehrmeyer SS; Laessig RH; Leinweber JE; Oryall JJ
    Clin Chem; 1990 Oct; 36(10):1736-40. PubMed ID: 2170059
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intralaboratory performance requirements necessary to pass proficiency testing: CAP-1990 vs CLIA-1967 (March 14, 1990) formats compared.
    Laessig RH; Ehrmeyer SS; Leinweber JE
    Clin Chem; 1992 Jun; 38(6):895-903. PubMed ID: 1597015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proficiency testing performance in US laboratories: results reported to the Centers for Medicare & Medicaid Services, 1994 through 2006.
    Howerton D; Krolak JM; Manasterski A; Handsfield JH
    Arch Pathol Lab Med; 2010 May; 134(5):751-8. PubMed ID: 20441507
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An assessment of the use of fixed limits to characterize intralaboratory performance by proficiency testing.
    Ehrmeyer SS; Laessig RH
    Clin Chem; 1987 Oct; 33(10):1901-2. PubMed ID: 3665047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The detection of problem analytes in a single proficiency test challenge in the absence of the Health Care Financing Administration rule violations.
    Cembrowski GS; Hackney JR; Carey N
    Arch Pathol Lab Med; 1993 Apr; 117(4):437-43. PubMed ID: 8466413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variation in proficiency testing performance by testing site.
    Stull TM; Hearn TL; Hancock JS; Handsfield JH; Collins CL
    JAMA; 1998 Feb; 279(6):463-7. PubMed ID: 9466641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Health Care Financing Administration's new proficiency testing rules. Use of a statistical approach to predict long-term performance using the categories 'successful,' 'probation,' and 'suspended'.
    Laessig RH; Ehrmeyer SS; Leinweber JE
    Arch Pathol Lab Med; 1992 Jul; 116(7):770-6. PubMed ID: 1497452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of computer modeling to predict the magnitude of intralaboratory error tolerated by proposed CDC interlaboratory proficiency testing performance criteria.
    Laessig RH; Ehrmeyer SS
    Clin Chem; 1988 Sep; 34(9):1849-53. PubMed ID: 2843307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interlaboratory proficiency-testing programs: a computer model to assess their capability to correctly characterize intralaboratory performance.
    Ehrmeyer SS; Laessig RH
    Clin Chem; 1987 Jun; 33(6):784-7. PubMed ID: 3594814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medicare, Medicaid and CLIA programs; revision of the laboratory regulations for the Medicare, Medicaid, and Clinical Laboratories Improvement Act of 1967 programs--HCFA. Final rule with comment period.
    Fed Regist; 1990 Mar; 55(50):9538-610. PubMed ID: 10106480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical laboratory performance on proficiency testing samples--United States, 1994.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1996 Mar; 45(9):193-6. PubMed ID: 8604217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relationship of intralaboratory bias and imprecision on laboratories' ability to meet medical usefulness limits.
    Ehrmeyer SS; Laessig RH
    Am J Clin Pathol; 1988 Jan; 89(1):14-8. PubMed ID: 3337048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medicare, Medicaid, and CLIA programs; extension of certain effective dates for clinical laboratory requirements under CLIA--CDC, HCFA. Final rule with comment period.
    Fed Regist; 1998 Oct; 63(198):55031-4. PubMed ID: 10185832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Matrix effects on proficiency testing materials. Impact on accuracy of cholesterol measurement in laboratories in the nation's largest hospital system.
    Naito HK; Kwak YS; Hartfiel JL; Park JK; Travers EM; Myers GL; Ross JW; Eckfeldt JH; Hartmann AE
    Arch Pathol Lab Med; 1993 Apr; 117(4):345-51. PubMed ID: 8466396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medicare program; Medicare and laboratory certification program; enforcement procedures for laboratories--HCFA. Final rule.
    Fed Regist; 1992 Feb; 57(40):7218-43. PubMed ID: 10117065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medicare, Medicaid, and CLIA programs; clinical laboratory requirements--extension of certain effective dates for clinical laboratory requirements under CLIA--CDC, HCFA. Final rule with comment period.
    Fed Regist; 1997 May; 62(91):25855-8. PubMed ID: 10173015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Accuracy-based proficiency testing for estradiol measurements.
    Tim Cao Z; Rej R; Vesper H; Rex Astles J
    Clin Biochem; 2024 Feb; 124():110700. PubMed ID: 38043696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ability of the 1(2)s rule to detect substandard performance in interlaboratory proficiency testing.
    Ehrmeyer SS; Laessig RH
    Clin Chem; 1987 Jun; 33(6):788-91. PubMed ID: 3594815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medicare and Medicaid programs; Medicare, Medicaid, and Clinical Laboratories Improvement Act (CLIA) patient confidentiality rules--PHS and HCFA. Final rule.
    Fed Regist; 1988 Dec; 53(232):48645-8. PubMed ID: 10302929
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medicare, Medicaid and CLIA programs; extension of certain effective dates for clinical laboratory requirements and personnel requirements for cytologists--HCFA. Final rule with comment period.
    Fed Regist; 1994 Dec; 59(233):62606-9. PubMed ID: 10138980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.